A Randomized, Parallel-group, Double Blind, Clinical Trial, to Asses the Safety and Efficacy of Topically Applied FXFM244 Antibiotic Foam in the Treatment of Impetigo.

Trial Profile

A Randomized, Parallel-group, Double Blind, Clinical Trial, to Asses the Safety and Efficacy of Topically Applied FXFM244 Antibiotic Foam in the Treatment of Impetigo.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Dec 2013

At a glance

  • Drugs Minocycline (Primary)
  • Indications Bacterial infections; Impetigo
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jun 2013 Results presented at BioMed according to a Foamix media release.
    • 24 Apr 2012 Actual end date Apr 2012 added as reported by ClinicalTrials.gov.
    • 14 Mar 2012 Status changed from recruiting to completed based on information reported in a Foamix media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top